Strategies for construction of the all-carbon macrocyclic skeleton of the ansamycin antibiotic—kendomycin

Shu Xu,Hirokazu Arimoto
DOI: https://doi.org/10.1038/ja.2016.5
2016-02-10
The Journal of Antibiotics
Abstract:Kendomycin, an ansamycin-type natural product first reported in 1996, possesses a series of attractive bioactivities and a unique all-carbon macrocyclic skeleton. To the date, seven total syntheses, two formal total syntheses and a number of synthetic studies on this hot molecule have been reported. In this short review article, we mainly survey and comment on these efforts regarding the difficult macrocyclization strategies.
pharmacology & pharmacy,immunology,biotechnology & applied microbiology,microbiology
What problem does this paper attempt to address?